NCT04405778View on ClinicalTrials.gov

A Study of TAK-102 in Adult With Previously-Treated Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

May 9, 2025

Study Completion Date

May 9, 2025

Conditions
Solid Tumors
Interventions
BIOLOGICAL

TAK-102

TAK-102 intravenous infusion

Trial Locations (3)

Unknown

National Cancer Center Hospital East, Kashiwa

National Cancer Center Hospital, Chuo-ku

Kyoto University Hospital, Kyoto

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY